{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["DNA damage", "cell apoptosis", "dioscin", "p53 signal", "skin cancer"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "33281970", "DateRevised": {"Year": "2020", "Month": "12", "Day": "08"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "11", "Day": "19"}], "Language": ["eng"], "ELocationID": ["59", "10.3892/ol.2020.12321"], "Journal": {"ISSN": "1792-1074", "JournalIssue": {"Volume": "21", "Issue": "1", "PubDate": {"Year": "2021", "Month": "Jan"}}, "Title": "Oncology letters", "ISOAbbreviation": "Oncol Lett"}, "ArticleTitle": "Antitumor effects of dioscin in A431 cells via adjusting ATM/p53-mediated cell apoptosis, DNA damage and migration.", "Pagination": {"StartPage": "59", "MedlinePgn": "59"}, "Abstract": {"AbstractText": ["Skin cancer is the deadliest type of malignant disease and causes primary mortality worldwide. Dioscin, which exists in medicinal plants, has potent anticancer effects. However, its effects on skin cancer remain unknown. In the present study, the activity and mechanism of dioscin on the human skin cancer A431 cell line were investigated, MTT, colony formation, Transwell, wound-healing, TUNEL, Comet, immunofluorescence and western blot assays were used to assess the effects of dioscin on A431 cells. The results of MTT, colony formation, Transwell and wound-healing assays revealed that dioscin suppressed proliferation, colony formation and invasion of the cancer cells. TUNEL and comet assays demonstrated that dioscin exhibited significant effects on cell apoptosis and DNA damage. Investigations into the mechanism revealed that the expression levels of phosphorylated Ataxia telangiectasia-mutated (ATM) were considerably activated by dioscin, which significantly upregulated the expression levels of p53 to activate mitochondrial apoptosis signaling. Furthermore, the expression levels of BAX, cleaved caspase-3/9 and cleaved poly (ADP-ribose) polymerase were upregulated, and the expression levels of BCL-2 were downregulated by dioscin. Additionally, dioscin markedly downregulated the expression levels of matrix metalloproteinase 2 (MMP2), MMP9, RHO and cdc42, which are all associated with tumor invasion. In addition, p53-small interfering RNA transfection experiments indicated that dioscin exhibited excellent activity against skin cancer <i>in vitro</i> by decreasing p53 expression. Overall, the present results suggested that dioscin inhibited skin cancer cell proliferation via adjusting ATM/p53-mediated cell apoptosis, migration and DNA damage, which should be considered as a potential option for future treatments of skin cancer."], "CopyrightInformation": "Copyright: \u00a9 Wang et al."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Liaoning University of Traditional Chinese Medicine, Shenyang, Liaoning 110847, P.R. China."}], "LastName": "Wang", "ForeName": "Peng", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Liaoning University of Traditional Chinese Medicine, Shenyang, Liaoning 110847, P.R. China."}], "LastName": "Wang", "ForeName": "Chun", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Liaoning University of Traditional Chinese Medicine, Shenyang, Liaoning 110847, P.R. China."}], "LastName": "Liu", "ForeName": "Chunying", "Initials": "C"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Greece", "MedlineTA": "Oncol Lett", "NlmUniqueID": "101531236", "ISSNLinking": "1792-1074"}}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Trakatelli M, Ulrich C, del Marmol V, Euvrard S, Stockfleth E, Abeni D. Epidemiology of nonmelanoma skin cancer (NMSC) in Europe: Accurate and comparable data are needed for effective public health monitoring and interventions. Br J Dematol. 2007;156(Suppl 3):S1\u2013S7. doi: 10.1111/j.1365-2133.2007.07861.x.", "ArticleIdList": ["10.1111/j.1365-2133.2007.07861.x", "17488399"]}, {"Citation": "Karia PS, Han J, Schmults CD. Cutaneous squamous cell carcinoma: Estimated incidence of disease, nodal metastasis, and deaths from disease in the United States, 2012. J Am Acad Dermatol. 2013;68:957\u2013966. doi: 10.1016/j.jaad.2012.11.037.", "ArticleIdList": ["10.1016/j.jaad.2012.11.037", "23375456"]}, {"Citation": "Li Q, Peng YS, Chen PJ, Wang ML, Cao C, Xiong H, Zhang J, Chen MH, Peng XB, Zeng K. Peroxisome proliferator-activated receptor-\u03b3 agonist-mediated inhibition of cell growth is independent of apoptosis in human epidermoid carcinoma A431 cells. Oncol Lett. 2018;15:6578\u20136584.", "ArticleIdList": ["PMC5920377", "29725405"]}, {"Citation": "Zhai XX, Ding JC, Tang ZM, Li JG, Li YC, Yan YH, Sun JC, Zhang CX. Effects of resveratrol on the proliferation, apoptosis and telomerase ability of human A431 epidermoid carcinoma cells. Oncol Lett. 2016;11:3015\u20133018. doi: 10.3892/ol.2016.4351.", "ArticleIdList": ["10.3892/ol.2016.4351", "PMC4840784", "27123055"]}, {"Citation": "Li H, Tang Z, Chu P, Song Y, Yang Y, Sun B, Niu M, Qaed E, Shopit A, Han G, et al. Neuroprotective effect of phosphocreatine on oxidative stress and mitochondrial dysfunction induced apoptosis in vitro and in vivo: Involvement of dual PI3K/Akt and Nrf2/HO-1 pathways. Free Radic Biol Med. 2018;120:228\u2013238. doi: 10.1016/j.freeradbiomed.2018.03.014.", "ArticleIdList": ["10.1016/j.freeradbiomed.2018.03.014", "29559323"]}, {"Citation": "Afaq F, Katiyar SK. Polyphenols: Skin photoprotection and inhibition of photocarcinogenesis. Mini Rev Med Chem. 2011;11:1200\u20131215. doi: 10.2174/138955711804586739.", "ArticleIdList": ["10.2174/138955711804586739", "PMC3288507", "22070679"]}, {"Citation": "Sajadimajd S, Bahramsoltani R, Iranpanah A, Kumar Patra J, Das G, Gouda S, Rahimi R, Rezaeiamiri E, Cao H, Giampieri F, et al. Advances on natural polyphenols as anticancer agents for skin cancer. Pharmacol Res. 2020;151:104584. doi: 10.1016/j.phrs.2019.104584.", "ArticleIdList": ["10.1016/j.phrs.2019.104584", "31809853"]}, {"Citation": "Zhang Y, Xu Y, Qi Y, Xu L, Song S, Yin L, Tao X, Zhen Y, Han X, Ma X, et al. Protective effects of dioscin against doxorubicin-induced nephrotoxicity via adjusting FXR-mediated oxidative stress and inflammation. Toxicology. 2017;378:53\u201364. doi: 10.1016/j.tox.2017.01.007.", "ArticleIdList": ["10.1016/j.tox.2017.01.007", "28082111"]}, {"Citation": "Xia Y, Jia C, Xue Q, Jiang J, Xie Y, Wang R, Ran Z, Xu F, Zhang Y, Ye T. Antipsychotic drug trifluoperazine suppresses colorectal cancer by inducing G0/G1 arrest and apoptosis. Front Pharmacol. 2019;10:1029. doi: 10.3389/fphar.2019.01029.", "ArticleIdList": ["10.3389/fphar.2019.01029", "PMC6753363", "31572198"]}, {"Citation": "Yao H, Sun Y, Song S, Qi Y, Tao X, Xu L, Yin L, Han X, Xu Y, Li H, et al. Protective effects of dioscin against lipopolysaccharide-induced acute lung injury through inhibition of oxidative stress and inflammation. Front Pharmacol. 2017;8:120. doi: 10.3389/fphar.2017.00120.", "ArticleIdList": ["10.3389/fphar.2017.00120", "PMC5359219", "28377715"]}, {"Citation": "Li XJ, Li ZF, Wang JJ, Han Z, Liu Z, Liu BG. Effects of microRNA-374 on proliferation, migration, invasion, and apoptosis of human SCC cells by targeting Gadd45a through P53 signaling pathway. Biosci Rep. 2017;37:BSR20170710. doi: 10.1042/BSR20170710.", "ArticleIdList": ["10.1042/BSR20170710", "PMC6435473", "28679648"]}, {"Citation": "Mao Z, Han X, Chen D, Xu Y, Xu L, Yin L, Sun H, Qi Y, Fang L, Liu K, Peng J. Potent effects of dioscin against hepatocellular carcinoma through regulating TP53-induced glycolysis and apoptosis regulator (TIGAR)-mediated apoptosis, autophagy and DNA damage. Br J Pharmacol. 2019;176:919\u2013937. doi: 10.1111/bph.14594.", "ArticleIdList": ["10.1111/bph.14594", "PMC6433650", "30710454"]}, {"Citation": "Si L, Xu L, Yin L, Qi Y, Han X, Xu Y, Zhao Y, Liu K, Peng J. Potent effects of dioscin against pancreatic cancer via miR-149-3P-mediated inhibition of the Akt1 signaling pathway. Br J Pharmacol. 2017;174:553\u2013568. doi: 10.1111/bph.13718.", "ArticleIdList": ["10.1111/bph.13718", "PMC5345629", "28095588"]}, {"Citation": "Sun D, Yu M, Li Y, Xing H, Gao Y, Huang Z, Hao W, Lu K, Kong C, Shimozato O, et al. Histone deacetylase 2 is involved in DNA damage-mediated cell death of human osteosarcoma cells through stimulation of the ATM/p53 pathway. FEBS Open Bio. 2019;9:478\u2013489. doi: 10.1002/2211-5463.12585.", "ArticleIdList": ["10.1002/2211-5463.12585", "PMC6396148", "30868056"]}, {"Citation": "Lavin MF, Kozlov S. ATM activation and DNA damage response. Cell Cycle. 2007;6:931\u2013942. doi: 10.4161/cc.6.8.4180.", "ArticleIdList": ["10.4161/cc.6.8.4180", "17457059"]}, {"Citation": "Hsu YL, Chia CC, Chen PJ, Huang SE, Huang SC, Kuo PL. Shallot and licorice constituent isoliquiritigenin arrests cell cycle progression and induces apoptosis through the induction of ATM/p53 and initiation of the mitochondrial system in human cervical carcinoma HeLa cells. Mol Nutr food Res. 2009;53:826\u2013835. doi: 10.1002/mnfr.200800288.", "ArticleIdList": ["10.1002/mnfr.200800288", "19536869"]}, {"Citation": "Tao X, Sun X, Yin L, Han X, Xu L, Qi Y, Xu Y, Li H, Lin Y, Liu K, Peng J. Dioscin ameliorates cerebral ischemia/reperfusion injury through the downregulation of TLR4 signaling via HMGB-1 inhibition. Free Radical Bio Med. 2015;84:103\u2013115. doi: 10.1016/j.freeradbiomed.2015.03.003.", "ArticleIdList": ["10.1016/j.freeradbiomed.2015.03.003", "25772012"]}, {"Citation": "Sun M, Ren J, Du H, Zhang Y, Zhang J, Wang S, He L. A combined A431 cell membrane chromatography and online high performance liquid chromatography /mass spectrometry method for screening compounds from total alkaloid of Radix Caulophylli acting on the human EGFR. J Chromatogr B Analyt Technol Biomed Life Sci. 2010;878:2712\u20132718. doi: 10.1016/j.jchromb.2010.08.010.", "ArticleIdList": ["10.1016/j.jchromb.2010.08.010", "20829129"]}, {"Citation": "Pliskova M, Vondracek J, Kren V, Gazak R, Sedmera P, Walterova D, Psotova J, Simanek V, Machala M. Effects of silymarin flavonolignans and synthetic silybin derivatives on estrogen and aryl hydrocarbon receptor activation. Toxicology. 2005;215:80\u201389. doi: 10.1016/j.tox.2005.06.020.", "ArticleIdList": ["10.1016/j.tox.2005.06.020", "16076518"]}, {"Citation": "Zhao L, Tao X, Qi Y, Xu L, Yin L, Peng J. Protective effect of dioscin against doxorubicin-induced cardiotoxicity via adjusting microRNA-140-5p-mediated myocardial oxidative stress. Redox Bio. 2018;16:189\u2013198. doi: 10.1016/j.redox.2018.02.026.", "ArticleIdList": ["10.1016/j.redox.2018.02.026", "PMC5953242", "29524841"]}, {"Citation": "Yao H, Tao X, Xu L, Qi Y, Yin L, Han X, Xu Y, Zheng L, Peng J. Dioscin alleviates non-alcoholic fatty liver disease through adjusting lipid metabolism via SIRT1/AMPK signaling pathway. Pharmacol Res. 2018;131:51\u201360. doi: 10.1016/j.phrs.2018.03.017.", "ArticleIdList": ["10.1016/j.phrs.2018.03.017", "29574225"]}, {"Citation": "Hu Y, Mao Z, Xu L, Yin L, Tao X, Tang Z, Qi Y, Sun P, Peng J. Protective effect of dioscin against intestinal ischemia/reperfusion injury via adjusting miR-351-5p-mediated oxidative stress. Pharmacol Res. 2018;137:56\u201363. doi: 10.1016/j.phrs.2018.09.016.", "ArticleIdList": ["10.1016/j.phrs.2018.09.016", "30240824"]}, {"Citation": "Zheng L, Han X, Hu Y, Zhao X, Yin L, Xu L, Qi Y, Xu Y, Han X, Liu K, Peng J. Dioscin ameliorates intestinal ischemia/ reperfusion injury via adjusting miR-351-5p/MAPK13-mediated inflammation and apoptosis. Pharmacol Res. 2019;139:431\u2013439. doi: 10.1016/j.phrs.2018.11.040.", "ArticleIdList": ["10.1016/j.phrs.2018.11.040", "30503840"]}, {"Citation": "Qiao Y, Xu L, Tao X, Yin L, Qi Y, Xu Y, Han X, Tang Z, Ma X, Liu K, Peng J. Protective effects of dioscin against fructose-induced renal damage via adjusting Sirt3-mediated oxidative stress, fibrosis, lipid metabolism and inflammation. Toxicol Lett. 2018;284:37\u201345. doi: 10.1016/j.toxlet.2017.11.031.", "ArticleIdList": ["10.1016/j.toxlet.2017.11.031", "29197622"]}, {"Citation": "Zheng L, Yin L, Xu L, Qi Y, Li H, Xu Y, Han X, Liu K, Peng J. Potective effect of dioscin against thioacetamide-induced acute liver injury via FXR/AMPK signaling pathway in vivo. Biomed Pharmacother. 2018;97:481\u2013488. doi: 10.1016/j.biopha.2017.10.153.", "ArticleIdList": ["10.1016/j.biopha.2017.10.153", "29091898"]}, {"Citation": "Yin L, Qi Y, Xu Y, Xu L, Han X, Tao X, Song S, Peng J. Dioscin inhibits HSC-T6 cell migration via adjusting SDC-4: Insights from iTRAQ-based quantitative proteomics. Front Pharmacol. 2017;8:665. doi: 10.3389/fphar.2017.00665.", "ArticleIdList": ["10.3389/fphar.2017.00665", "PMC5627034", "29033837"]}, {"Citation": "Zhang Y, Tao X, Yin L, Xu L, Xu Y, Qi Y, Han X, Song S, Zhao Y, Lin Y, et al. Protective effects of dioscin against cisplatin-induced nephrotoxicity via regulating miR-34a/Sirt1 signal pathway. Br J Pharmacol. 2017;174:2512\u20132527. doi: 10.1111/bph.13862.", "ArticleIdList": ["10.1111/bph.13862", "PMC5513863", "28514495"]}, {"Citation": "Yao H, Xu Y, Yin L, Tao X, Xu L, Qi Y, Han X, Sun P, Liu K, Peng J. Dioscin protects ANIT-induced intrahepatic cholestasis through regulating transporters, apoptosis and oxidative stress. Front Pharmacol. 2017;8:116. doi: 10.3389/fphar.2017.00116.", "ArticleIdList": ["10.3389/fphar.2017.00116", "PMC5340742", "28337145"]}, {"Citation": "Hu Y, Tao X, Han X, Xu L, Yin L, Qi Y, Zhao Y, Xu Y, Wang C, Peng J. Dioscin attenuates gastric ischemia/reperfusion injury through the down-regulation of PKC/ERK1/2 signaling via PKC\u03b1 and PKC\u03b22 inhibition. Chem Bio Interact. 2016;258:234\u2013244. doi: 10.1016/j.cbi.2016.09.014.", "ArticleIdList": ["10.1016/j.cbi.2016.09.014", "27649624"]}, {"Citation": "Qi M, Yin L, Xu L, Tao X, Qi Y, Han X, Wang C, Xu Y, Sun H, Liu K, Peng J. Dioscin alleviates lipopolysaccharide-induced inflammatory kidney injury via the microRNA let-7i/TLR4/MyD88 signaling pathway. Pharmacol Res. 2016;111:509\u2013522. doi: 10.1016/j.phrs.2016.07.016.", "ArticleIdList": ["10.1016/j.phrs.2016.07.016", "27431331"]}, {"Citation": "Tao X, Yin L, Xu L, Peng J. Dioscin: A diverse acting natural compound with therapeutic potential in metabolic diseases, cancer, inflammation and infections. Pharmacol Res. 2018;137:259\u2013269. doi: 10.1016/j.phrs.2018.09.022.", "ArticleIdList": ["10.1016/j.phrs.2018.09.022", "30315966"]}, {"Citation": "Zhao X, Yin L, Fang L, Xu L, Sun P, Xu M, Liu K, Peng J. Protective effects of dioscin against systemic inflammatory response syndromevia adjusting TLR2/MyD88/NF-\u03bab signal pathway. Int Immunopharmacol. 2018;65:458\u2013469. doi: 10.1016/j.intimp.2018.10.036.", "ArticleIdList": ["10.1016/j.intimp.2018.10.036", "30390593"]}, {"Citation": "Lv L, Zheng L, Dong D, Xu L, Yin L, Xu Y, Qi Y, Han X, Peng J. Dioscin, a natural steroid saponin, induces apoptosis and DNA damage through reactive oxygen species: A potential new drug for treatment of glioblastoma multiforme. Food Chem Toxicol. 2013;59:657\u2013669. doi: 10.1016/j.fct.2013.07.012.", "ArticleIdList": ["10.1016/j.fct.2013.07.012", "23871826"]}, {"Citation": "Si L, Zheng L, Xu L, Yin L, Han X, Qi Y, Xu Y, Wang C, Peng J. Dioscin suppresses human laryngeal cancer cells growth via induction of cell-cycle arrest and MAPK-mediated mitochondrial-derived apoptosis and inhibition of tumor invasion. Eur J Pharmacol. 2016;774:105\u2013117. doi: 10.1016/j.ejphar.2016.02.009.", "ArticleIdList": ["10.1016/j.ejphar.2016.02.009", "26849940"]}, {"Citation": "Tao X, Xu L, Yin L, Han X, Qi Y, Xu Y, Song S, Zhao Y, Peng J. Dioscin induces prostate cancer cell apoptosis through activation of estrogen receptor-\u03b2. Cell Death Dis. 2017;8:e2989. doi: 10.1038/cddis.2017.391.", "ArticleIdList": ["10.1038/cddis.2017.391", "PMC5596577", "28796245"]}, {"Citation": "Wei Y, Xu Y, Han X, Qi Y, Xu L, Xu Y, Yin L, Sun H, Liu K, Peng J. Anti-cancer effects of dioscin on three kinds of human lung cancer cell lines through inducing DNA damage and activating mitochondrial signal pathway. Food Chem Toxicol. 2013;59:118\u2013128. doi: 10.1016/j.fct.2013.05.054.", "ArticleIdList": ["10.1016/j.fct.2013.05.054", "23764357"]}, {"Citation": "Zhao X, Tao X, Xu L, Yin L, Qi Y, Xu Y, Han X, Peng J. Dioscin induces apoptosis in human cervical carcinoma HeLa and SiHa cells through ROS-mediated DNA damage and the mitochondrial signaling pathway. Molecules. 2016;21:730. doi: 10.3390/molecules21060730.", "ArticleIdList": ["10.3390/molecules21060730", "PMC6273920", "27271587"]}, {"Citation": "Zhao X, Xu L, Zheng L, Yin L, Qi Y, Han X, Xu Y, Peng J. Potent effects of dioscin against gastric cancer in vitro and in vivo. Phytomedicine. 2016;23:274\u2013282. doi: 10.1016/j.phymed.2016.01.012.", "ArticleIdList": ["10.1016/j.phymed.2016.01.012", "26969381"]}, {"Citation": "Kou Y, Ji L, Wang H, Wang W, Zheng H, Zhou J, Liu L, Qi X, Liu Z, Du B, Lu L. Connexin 43 upregulation by dioscin inhibits melanoma progression via suppressing malignancy and inducing M1 polarization. Int J Cancer. 2017;141:1690\u20131703. doi: 10.1002/ijc.30872.", "ArticleIdList": ["10.1002/ijc.30872", "28677156"]}, {"Citation": "Wang Y, Fu M, Liu J, Yang Y, Yu Y, Li J, Pan W, Fan L, Li G, Li X, Wang X. Inhibition of tumor metastasis by targeted daunorubicin and dioscin codelivery liposomes modified with PFV for the treatment of non-small-cell lung cancer. Int J Nanomedicine. 2019;14:4071\u20134090. doi: 10.2147/IJN.S194304.", "ArticleIdList": ["10.2147/IJN.S194304", "PMC6551515", "31239668"]}, {"Citation": "Zeng N, Hongbo T, Xu Y, Wu M, Wu Y. Anticancer activity of caffeic acid nbutyl ester against A431 skin carcinoma cell line occurs via induction of apoptosis and inhibition of the mTOR/PI3K/AKT signaling pathway. Mol Med Rep. 2018;17:5652\u20135657.", "ArticleIdList": ["PMC5866006", "29436638"]}, {"Citation": "Zhao J, Xu Y, Wang C, Ding Y, Chen M, Wang Y, Peng J, Li L, Lv L. Soluplus/TPGS mixed micelles for dioscin delivery in cancer therapy. Drug Dev Ind Pharm. 2017;43:1197\u20131204. doi: 10.1080/03639045.2017.1304956.", "ArticleIdList": ["10.1080/03639045.2017.1304956", "28300426"]}, {"Citation": "Zhang Z, Wang CZ, Du GJ, Qi LW, Calway T, He TC, Du W, Yuan CS. Genistein induces G2/M cell cycle arrest and apoptosis via ATM/p53-dependent pathway in human colon cancer cells. Int J Oncol. 2013;43:289\u2013296. doi: 10.3892/ijo.2013.1946.", "ArticleIdList": ["10.3892/ijo.2013.1946", "PMC3742162", "23686257"]}, {"Citation": "Ling G, Ahmadian A, Persson A, Unden AB, Afink G, Williams C, Uhl\u00e9n M, Toftg\u00e5rd R, Lundeberg J, Pont\u00e9n F. PATCHED and p53 gene alterations in sporadic and hereditary basal cell cancer. Oncogene. 2001;53:7770\u20137778. doi: 10.1038/sj.onc.1204946.", "ArticleIdList": ["10.1038/sj.onc.1204946", "11753655"]}, {"Citation": "Chang IY, Kim JH, Park KH, Yoon SP. Experimental varicocele induces p53-dependent germ cell apoptosis through activation of \u03b3-H2AX. Urol Int. 2010;85:216\u2013220. doi: 10.1159/000316356.", "ArticleIdList": ["10.1159/000316356", "20530960"]}, {"Citation": "Lee CF, Yang JS, Tsai FJ, Chiang NN, Lu CC, Huang YS, Chen C, Chen FA. Kaempferol induces ATM/p53-mediated death receptor and mitochondrial apoptosis in human umbilical vein endothelial cells. Int J Oncol. 2016;48:2007\u20132014. doi: 10.3892/ijo.2016.3420.", "ArticleIdList": ["10.3892/ijo.2016.3420", "26984266"]}, {"Citation": "Maira F, Catania A, Candido S, Russo AE, McCubrey JA, Libra M, Malaponte G, Fenga C. Molecular targeted therapy in melanoma: A way to reverse resistance to conventional drugs. Curr Drug Deliv. 2012;9:17\u201329. doi: 10.2174/156720112798376032.", "ArticleIdList": ["10.2174/156720112798376032", "22023213"]}, {"Citation": "Liu J, Yin S, Reddy N, Spencer C, Sheng S. Bax mediates the apoptosis-sensitizing effect of maspin. Cancer Res. 2004;64:1703\u20131711. doi: 10.1158/0008-5472.CAN-03-2568.", "ArticleIdList": ["10.1158/0008-5472.CAN-03-2568", "14996730"]}, {"Citation": "Nikolaou V, Stratigos A, Bafaloukos D, Katsambas A. Antiangiogenic and antiapoptotic treatment in advanced melanoma. Clin Dermatol. 2013;31:257\u2013263. doi: 10.1016/j.clindermatol.2012.08.018.", "ArticleIdList": ["10.1016/j.clindermatol.2012.08.018", "23608445"]}, {"Citation": "Sarig-Nadir O, Seliktar D. The role of matrix metalloproteinases in regulating neuronal and nonneuronal cell invasion into PEGylated fibrinogen hydrogels. Biomaterials. 2010;31:6411\u20136416. doi: 10.1016/j.biomaterials.2010.04.052.", "ArticleIdList": ["10.1016/j.biomaterials.2010.04.052", "20537384"]}, {"Citation": "Zhu Y, Zhou J, Xia H, Chen X, Qiu M, Huang J, Liu S, Tang Q, Lang N, Liu Z, et al. The Rho GTPase RhoE is a p53-regulated candidate tumor suppressor in cancer cells. Int J Oncol. 2014;44:896\u2013904. doi: 10.3892/ijo.2014.2245.", "ArticleIdList": ["10.3892/ijo.2014.2245", "24399089"]}, {"Citation": "Takeba Y, Matsumoto N, Watanabe M, Takenoshita-Nakaya S, Ohta Y, Kumai T, Takagi M, Koizumi S, Asakura T, Otsubo T. The Rho kinase inhibitor fasudil is involved in p53-mediated apoptosis in human hepatocellular carcinoma cells. Cancer Chemother Pharmacol. 2012;69:1545\u20131555. doi: 10.1007/s00280-012-1862-6.", "ArticleIdList": ["10.1007/s00280-012-1862-6", "22481618"]}, {"Citation": "Dornan D, Shimizu H, Mah A, Dudhela T, Eby M, O'rourke K, Seshagiri S, Dixit VM. ATM engages autodegradation of the E3 ubiquitin ligase COP1 after DNA damage. Science. 2006;313:1122\u20131126. doi: 10.1126/science.1127335.", "ArticleIdList": ["10.1126/science.1127335", "16931761"]}]}], "History": [{"Year": "2020", "Month": "1", "Day": "24"}, {"Year": "2020", "Month": "10", "Day": "26"}, {"Year": "2020", "Month": "12", "Day": "7", "Hour": "5", "Minute": "32"}, {"Year": "2020", "Month": "12", "Day": "8", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "12", "Day": "8", "Hour": "6", "Minute": "1"}, {"Year": "2020", "Month": "11", "Day": "19"}], "PublicationStatus": "ppublish", "ArticleIdList": ["33281970", "PMC7709553", "10.3892/ol.2020.12321", "OL-0-0-12321"]}}]}